Also trades as: BDXB (NYSE) · $vol 22M · 0R19.L (LSE) · $vol 1M · BDX.SW (SIX) · BDXA (NYSE)

$147.63

+1.38 (+0.94%)

Weekly Expected Move ±5.0%

$129 $136 $143 $151 $158

NYSE · Healthcare · Medical - Instruments & Supplies · Alpha Radar Sell · Power 38 · $53.5B mcap · 362M float · 0.802% daily turnover · Short 49% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$21.8B +8.2% ▲

5Y CAGR: +6.3%

Gross Profit

$9.9B +8.8% ▲

5Y CAGR: +7.9%

Operating Income

$2.6B +7.6% ▲

5Y CAGR: +23.1%

Net Income

$1.7B -1.6% ▼

5Y CAGR: +13.9%

EPS (Diluted)

$5.83 -0.5% ▼

5Y CAGR: +16.6%

EBITDA

$5.0B +2.9% ▲

5Y CAGR: +10.2%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$19.1B	$18.9B	$19.4B	$20.2B	$21.8B
YoY Growth	+19.0%	-1.4%	+2.7%	+4.2%	+8.2%
Cost of Revenue	$10.5B	$10.4B	$11.2B	$11.1B	$11.9B
Gross Profit	$8.6B	$8.5B	$8.2B	$9.1B	$9.9B
Gross Margin	45.1%	44.9%	42.2%	45.2%	45.4%
R&D Expenses	$1.3B	$1.3B	$1.2B	$1.2B	$1.3B
SG&A Expenses	$4.7B	$4.7B	$4.7B	$4.9B	$5.3B
Operating Expenses	$6.4B	$6.2B	$6.1B	$6.7B	$7.3B
Operating Income	$2.2B	$2.3B	$2.1B	$2.4B	$2.6B
Operating Margin	11.8%	12.1%	10.9%	11.9%	11.8%
Interest Expense	$469M	$398M	$452M	$528M	$613M
Income Before Tax	$1.7B	$1.8B	$1.7B	$2.0B	$1.9B
Tax Expense	$88M	$148M	$132M	$300M	$204M
Net Income	$2.1B	$1.8B	$1.5B	$1.7B	$1.7B
Net Margin	10.9%	9.4%	7.7%	8.4%	7.7%
EPS (Diluted)	$6.85	$5.88	$4.94	$5.86	$5.83
EBITDA	$4.4B	$4.4B	$4.4B	$4.8B	$5.0B
Shares Outstanding	292M	287M	288M	291M	287M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$5.0B	$5.4B	$5.2B	$5.3B	$5.5B	$5.9B	$5.3B	$4.7B
Cost of Revenue	$2.7B	$2.9B	$2.9B	$3.0B	$2.9B	$3.1B	$2.9B	$2.6B
Gross Profit	$2.3B	$2.5B	$2.2B	$2.3B	$2.6B	$2.8B	$2.3B	$2.2B
Gross Margin	46.2%	46.3%	43.2%	42.8%	47.8%	47.5%	44.6%	45.7%
R&D Expenses	$299M	$302M	$343M	$302M	$297M	$322M	$318M	$249M
SG&A Expenses	$1.2B	$1.3B	$1.3B	$1.3B	$1.3B	$1.4B	$1.4B	$1.2B
Operating Expenses	$1.7B	$1.7B	$1.8B	$1.7B	$1.8B	$2.1B	$1.8B	$2.1B
Operating Income	$602M	$820M	$453M	$546M	$882M	$697M	$594M	$94M
Operating Margin	12.1%	15.1%	8.8%	10.4%	16.0%	11.8%	11.3%	2.0%
Interest Expense	$137M	$155M	$155M	$151M	$152M	$155M	$107M	$149M
Income Before Tax	$500M	$542M	$306M	$363M	$703M	$510M	$487M	$39M
Tax Expense	$13M	$121M	$3M	$55M	$129M	$17M	$105M	$76M
Net Income	$487M	$421M	$303M	$308M	$574M	$493M	$382M	-$311M
Net Margin	9.8%	7.7%	5.9%	5.8%	10.4%	8.4%	7.3%	-6.6%
EPS (Diluted)	$1.68	$1.45	$1.04	$1.07	$2.00	$1.72	$1.34	$-1.11
EBITDA	$1.2B	$1.1B	$1.1B	$1.1B	$1.5B	$1.3B	$1.2B	$189M
Shares Outstanding	290M	291M	290M	289M	289M	287M	285M	281M

BDX NYSE